Evidence map›Paper›PMID 34190027›Full record

SynthesisGut microbes

Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.

Arjun Gandhi, Ayesha Shah, Michael P Jones, Natasha Koloski, Nicholas J Talley, Mark Morrison, Gerald Holtmann

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 7 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 7 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Therapeutic effects of olive leaf tea (Frontiers in nutrition · 2025
    Article
  18. Review
  19. [The Relationship of Dysbiosis of Duodenal Microbiome and Functional Dyspepsia].The Korean journal of helicobacter and upper gastrointestinal research · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Arjun GandhiFaculty of Medicine, The University of Queensland, Queensland, Australia.
Ayesha ShahFaculty of Medicine, The University of Queensland, Queensland, Australia.
Michael P JonesDepartment of Psychology, Macquarie University, Sydney, New South Wales, Australia.
Natasha KoloskiFaculty of Medicine, The University of Queensland, Queensland, Australia.
Nicholas J TalleyFaculty of Health and Medicine, The University of Newcastle, Newcastle, Australia.
Mark MorrisonFaculty of Medicine, The University of Queensland, Queensland, Australia.
Gerald HoltmannFaculty of Medicine, The University of Queensland, Queensland, Australia.
Princess Alexandra Hospital · AUThe University of Queensland · AUMacquarie University · AUTranslational Research Institute · AUUniversity of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies reported a potential role of methane producing archaea in the pathophysiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). We conducted a systematic review and meta-analysis to assess the prevalence of methane positive small intestinal bacterial overgrowth (SIBO) in IBS and IBD compared with controls. MEDLINE (PubMed) and Embase electronic databases were searched from inception until March 2021 for case-control and prevalence studies reporting SIBO in IBS and IBD. We extracted data from published studies and calculated pooled prevalence of SIBO in IBS or IBD, odds ratios (OR), and 95% CIs, utilizing a random effects model. The final dataset included 17 independent studies assessing the prevalence of methane positive SIBO in 1,653 IBS-patients and 713 controls, and 7 studies assessing the prevalence of methane positive SIBO in 626 IBD-patients and 497 controls, all utilizing breath test for SIBO diagnosis. Prevalence of methane positive SIBO in IBS and IBD was 25.0% (95% CI 18.8-32.4) and 5.6% (95% CI 2.6-11.8), respectively. Methane positive SIBO in IBS was not increased compared to controls (OR = 1.2, 95% CI 0.8-1.7,

Indexed as

BacteriaBreath TestsCase-Control StudiesFemaleHumansInflammatory Bowel DiseasesIntestine, SmallIrritable Bowel SyndromeMaleMethaneMethanebreath testsinflammatory bowel diseaseIrritable bowel syndromemethanesmall intestinal bacterial overgrowth

Identifiers

PMID34190027
PMCPMC8253120
OpenAlexW3174094388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.